Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel R McGrath

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Hereditary Cancer in Clinical Practice|March 18, 2010
In the beginning there was colectomy: current surgical options in familial adenomatous polyposisDaniel R McGrath, Allan D Spigelman
Expert Opinion on Therapeutic Targets|May 16, 2008
Putative mechanisms of action for indole-3-carbinol in the prevention of colorectal cancerDaniel R McGrath, Allan D Spigelman
The Medical Journal of Australia|February 14, 2002
Gastrointestinal surgeryAllan D Spigelman, Daniel R McGrath, Richard D Levy
ANZ Journal of Surgery|March 1, 2003
The effect of indole-3-carbinol and sulforaphane on a prostate cancer cell lineHamid R Frydoonfar, Daniel R McGrath, Allan D Spigelman
ANZ Journal of Surgery|January 17, 2004
Management of colorectal cancer patients in Australia: the National Colorectal Cancer Care SurveyDaniel R McGrath, David C Leong, Bruce K Armstrong, et al.
ANZ Journal of Surgery|September 24, 2005
Surgeon and hospital volume and the management of colorectal cancer patients in AustraliaDaniel R McGrath, David C Leong, Robert Gibberd, et al.
Therapeutics and Clinical Risk Management|June 8, 2010
Serum glutathione transferase does not respond to indole-3-carbinol: A pilot studyDaniel R McGrath, Hamid Frydoonfar, Joshua J Hunt, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Hereditary Cancer in Clinical Practice|March 18, 2010
In the beginning there was colectomy: current surgical options in familial adenomatous polyposisDaniel R McGrath, Allan D Spigelman
Expert Opinion on Therapeutic Targets|May 16, 2008
Putative mechanisms of action for indole-3-carbinol in the prevention of colorectal cancerDaniel R McGrath, Allan D Spigelman
The Medical Journal of Australia|February 14, 2002
Gastrointestinal surgeryAllan D Spigelman, Daniel R McGrath, Richard D Levy
ANZ Journal of Surgery|March 1, 2003
The effect of indole-3-carbinol and sulforaphane on a prostate cancer cell lineHamid R Frydoonfar, Daniel R McGrath, Allan D Spigelman
ANZ Journal of Surgery|January 17, 2004
Management of colorectal cancer patients in Australia: the National Colorectal Cancer Care SurveyDaniel R McGrath, David C Leong, Bruce K Armstrong, et al.
ANZ Journal of Surgery|September 24, 2005
Surgeon and hospital volume and the management of colorectal cancer patients in AustraliaDaniel R McGrath, David C Leong, Robert Gibberd, et al.
Therapeutics and Clinical Risk Management|June 8, 2010
Serum glutathione transferase does not respond to indole-3-carbinol: A pilot studyDaniel R McGrath, Hamid Frydoonfar, Joshua J Hunt, et al.
Pageof 1